The estimated Net Worth of Bioventures Iii Qp Lpmpm Bi... is at least 44.1 百万$ dollars as of 31 August 2004. Bioventures Bi owns over 85,853 units of Rigel Pharmaceuticals stock worth over 21,881,324$ and over the last 21 years Bioventures sold RIGL stock worth over 22,192,714$.
Bioventures has made over 16 trades of the Rigel Pharmaceuticals stock since 2004, according to the Form 4 filled with the SEC. Most recently Bioventures sold 85,853 units of RIGL stock worth 1,780,591$ on 31 August 2004.
The largest trade Bioventures's ever made was selling 316,302 units of Rigel Pharmaceuticals stock on 8 April 2004 worth over 6,303,899$. On average, Bioventures trades about 67,885 units every 11 days since 2004. As of 31 August 2004 Bioventures still owns at least 1,687,072 units of Rigel Pharmaceuticals stock.
You can see the complete history of Bioventures Bi stock trades at the bottom of the page.
Over the last 21 years, insiders at Rigel Pharmaceuticals have traded over 170,041,384$ worth of Rigel Pharmaceuticals stock and bought 2,068,700 units worth 7,281,949$ . The most active insiders traders include Partners L P/Ilbiotechnolog...、Ansbert Gadicke、Partners L P/Ilbiotechnolog.... On average, Rigel Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of 961,207$. The most recent stock trade was executed by David A Santos on 2 February 2024, trading 14,519 units of RIGL stock currently worth 16,552$.
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Rigel Pharmaceuticals executives and other stock owners filed with the SEC include: